Literature DB >> 15599406

T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

Xiao-Song He1, Monia Draghi, Kutubuddin Mahmood, Tyson H Holmes, George W Kemble, Cornelia L Dekker, Ann M Arvin, Peter Parham, Harry B Greenberg.   

Abstract

The role of human NK cells in viral infections is poorly understood. We used a cytokine flow-cytometry assay to simultaneously investigate the IFN-gamma response of NK and T lymphocytes to influenza A virus (fluA). When PBMCs from fluA-immune adult donors were incubated with fluA, IFN-gamma was produced by both CD56(dim) and CD56(bright) subsets of NK cells, as well as by fluA-specific T cells. Purified NK cells did not produce IFN-gamma in response to fluA, while depletion of T lymphocytes reduced to background levels the fluA-induced IFN-gamma production by NK cells, which indicates that T cells are required for the IFN-gamma response of NK cells. The fluA-induced IFN-gamma production of NK cells was suppressed by anti-IL-2 Ab, while recombinant IL-2 replaced the helper function of T cells for IFN-gamma production by NK cells. This indicates that IL-2 produced by fluA-specific T cells is involved in the T cell-dependent IFN-gamma response of NK cells to fluA. Taken together, these results suggest that at an early stage of recurrent viral infection, NK-mediated innate immunity to the virus is enhanced by preexisting virus-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599406      PMCID: PMC535070          DOI: 10.1172/JCI22797

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  Role of chemokines in the biology of natural killer cells.

Authors:  Michael J Robertson
Journal:  J Leukoc Biol       Date:  2002-02       Impact factor: 4.962

2.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.

Authors:  R Jacobs; G Hintzen; A Kemper; K Beul; S Kempf; G Behrens; K W Sykora; R E Schmidt
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

Review 4.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

5.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  Reciprocal activating interaction between natural killer cells and dendritic cells.

Authors:  Franca Gerosa; Barbara Baldani-Guerra; Carla Nisii; Viviana Marchesini; Giuseppe Carra; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

7.  Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.

Authors:  Robbie B Mailliard; Shinichi Egawa; Quan Cai; Anna Kalinska; Svetlana N Bykovskaya; Michael T Lotze; Martien L Kapsenberg; Walter J Storkus; Pawel Kalinski
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

Review 8.  Dendritic and natural killer cells cooperate in the control/switch of innate immunity.

Authors:  Laurence Zitvogel
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

9.  Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.

Authors:  Diego Piccioli; Silverio Sbrana; Emiliano Melandri; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

10.  Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells.

Authors:  Guido Ferlazzo; Ming L Tsang; Lorenzo Moretta; Giovanni Melioli; Ralph M Steinman; Christian Münz
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  74 in total

1.  Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine.

Authors:  Jeremy C Jones; Erik W Settles; Curtis R Brandt; Stacey Schultz-Cherry
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

Authors:  Xiao-Song He; Tyson H Holmes; Caiqiu Zhang; Kutubuddin Mahmood; George W Kemble; David B Lewis; Cornelia L Dekker; Harry B Greenberg; Ann M Arvin
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Authors:  Caroline T Tiemessen; Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Maria A Papathanasopoulos; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

4.  HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.

Authors:  Christopher P Loo; Brian R Long; Frederick M Hecht; Douglas F Nixon; Jakob Michaëlsson
Journal:  AIDS Res Hum Retroviruses       Date:  2009-06       Impact factor: 2.205

Review 5.  Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Authors:  Franck Bihl; Claire Germain; Carmelo Luci; Veronique M Braud
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 6.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

7.  Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help.

Authors:  Jing Ni; Oliver Hölsken; Matthias Miller; Quirin Hammer; Merlin Luetke-Eversloh; Chiara Romagnani; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

8.  Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.

Authors:  Lisa M Kronstad; Christof Seiler; Rosemary Vergara; Susan P Holmes; Catherine A Blish
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

9.  The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013.

Authors:  Fred Y Aoki; Upton D Allen; H Grant Stiver; Gerald A Evans
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

10.  Influenza a virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells.

Authors:  Sanda Sturlan; Monika Sachet; Suzann Baumann; Irina Kuznetsova; Andreas Spittler; Michael Bergmann
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.